tiprankstipranks
Glaukos price target raised to $176 from $149 at Needham
PremiumThe FlyGlaukos price target raised to $176 from $149 at Needham
1M ago
Glaukos price target raised to $160 from $153 at Wells Fargo
Premium
The Fly
Glaukos price target raised to $160 from $153 at Wells Fargo
1M ago
Glaukos: Surpassing Milestones with Robust Growth in Glaucoma Segment and Promising iDose Integration
Premium
Ratings
Glaukos: Surpassing Milestones with Robust Growth in Glaucoma Segment and Promising iDose Integration
1M ago
Glaukos reports Q4 EPS (40c), consensus (39c)
PremiumThe FlyGlaukos reports Q4 EPS (40c), consensus (39c)
1M ago
Glaukos sees FY25 revenue $475M-$485M, consensus $480.3M
Premium
The Fly
Glaukos sees FY25 revenue $475M-$485M, consensus $480.3M
1M ago
Notable companies reporting after market close
Premium
The Fly
Notable companies reporting after market close
1M ago
GKOS Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsGKOS Upcoming Earnings Report: What to Expect?
1M ago
Glaukos price target raised to $180 from $140 at Piper Sandler
Premium
The Fly
Glaukos price target raised to $180 from $140 at Piper Sandler
2M ago
Glaukos Highlights Advances in Glaucoma Treatments
Premium
Company Announcements
Glaukos Highlights Advances in Glaucoma Treatments
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100